Literature DB >> 32723770

A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization.

Tiffany Zhang1, Jin Xu1, Ying-Xian Pan2.   

Abstract

The μ-opioid receptor gene undergoes extensive alternative splicing to generate an array of splice variants. One group of splice variants excludes the first transmembrane (TM) domain and contains six TM domains. These 6TM variants are essential for the action of a novel class of analgesic drugs, including 3-iodobenzoyl-6β-naltrexamide, which is potent against a spectrum of pain models without exhibiting the adverse side effects of traditional opiates. The 6TM variants are also involved in analgesic action through other drug classes, including δ-opioid and κ-opioids and α 2-adrenergic drugs. Of the five 6TM variants in mouse, mouse μ-opioid receptor (mMOR)-1G is abundant and conserved from rodent to human. In the present study, we demonstrate a new function of mMOR-1G in enhancing expression of the full-length 7TM μ-opioid receptor, mMOR-1. When coexpressed with mMOR-1 in a Tet-Off inducible CHO cell line, mMOR-1G has no effect on mMOR-1 mRNA expression but greatly increases mMOR-1 protein expression in a dose-dependent manner determined by opioid receptor binding and [35S] guanosine 5'-3-O-(thio)triphosphate binding. Subcellular fractionation analysis using OptiPrep density gradient centrifugation shows an increase of functional mMOR-1 receptor in plasma membrane-enriched fractions. Using a coimmunoprecipitation approach, we further demonstrate that mMOR-1G physically associates with mMOR-1 starting at the endoplasmic reticulum, suggesting a chaperone-like function. These data provide a molecular mechanism for how mMOR-1G regulates expression and function of the full-length 7TM μ-opioid receptor. SIGNIFICANCE STATEMENT: The current study establishes a novel function of mouse μ-opioid receptor (mMOR)-1G, a truncated splice variant with six transmembrane (TM) domains of the mouse μ-opioid receptor gene, in enhancing expression of the full-length 7TM mMOR-1 through a chaperone-like function.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32723770      PMCID: PMC7562973          DOI: 10.1124/mol.120.119453

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.

Authors:  Susruta Majumdar; Joan Subrath; Valerie Le Rouzic; Lisa Polikar; Maxim Burgman; Kuni Nagakura; Julie Ocampo; Nathan Haselton; Anna R Pasternak; Steven Grinnell; Ying-Xian Pan; Gavril W Pasternak
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

2.  Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.

Authors:  Vipa Chaipatikul; Horace H Loh; P Y Law
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

Review 3.  Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters.

Authors:  Ying-Xian Pan
Journal:  DNA Cell Biol       Date:  2005-11       Impact factor: 3.311

4.  Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.

Authors:  Susruta Majumdar; Steven Grinnell; Valerie Le Rouzic; Maxim Burgman; Lisa Polikar; Michael Ansonoff; John Pintar; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

5.  Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor.

Authors:  Peng Huang; Chongguang Chen; Wei Xu; Su-In Yoon; Ellen M Unterwald; John E Pintar; Yulin Wang; Parkson Lee-Gau Chong; Lee-Yuan Liu-Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-10-31       Impact factor: 3.575

6.  A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism.

Authors:  Pavel Gris; Josee Gauthier; Philip Cheng; Dustin G Gibson; Denis Gris; Oskar Laur; John Pierson; Sean Wentworth; Andrea G Nackley; William Maixner; Luda Diatchenko
Journal:  Mol Pain       Date:  2010-06-02       Impact factor: 3.395

7.  Rescuing the traffic-deficient mutants of rat mu-opioid receptors with hydrophobic ligands.

Authors:  Vipa Chaipatikul; Laurie J Erickson-Herbrandson; Horace H Loh; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2003-07       Impact factor: 4.436

8.  The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.

Authors:  Thomas Kroslak; K Steven Laforge; Robert J Gianotti; Ann Ho; David A Nielsen; Mary Jeanne Kreek
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

9.  Differential expressions of the alternatively spliced variant mRNAs of the µ opioid receptor gene, OPRM1, in brain regions of four inbred mouse strains.

Authors:  Jin Xu; Zhigang Lu; Mingming Xu; Grace C Rossi; Benjamin Kest; Amanda R Waxman; Gavril W Pasternak; Ying-Xian Pan
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

Review 10.  Detection of the endogenous mu opioid receptor (mopr) in brain

Authors:  Peng Huang; Lee-Yuan Liu-Chen
Journal:  Front Biosci (Elite Ed)       Date:  2009-06-01
View more
  8 in total

Review 1.  Strategies towards safer opioid analgesics-A review of old and upcoming targets.

Authors:  Balazs R Varga; John M Streicher; Susruta Majumdar
Journal:  Br J Pharmacol       Date:  2021-11-26       Impact factor: 9.473

Review 2.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

Review 3.  Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions.

Authors:  Shan Liu; Wen-Jia Kang; Anna Abrimian; Jin Xu; Luca Cartegni; Susruta Majumdar; Patrick Hesketh; Alex Bekker; Ying-Xian Pan
Journal:  Biomolecules       Date:  2021-10-15

Review 4.  Spoken and Unspoken Matters Regarding the Use of Opioids in Cancer.

Authors:  Janna Baker Rogers; Gerald M Higa
Journal:  J Pain Res       Date:  2022-04-05       Impact factor: 3.133

Review 5.  Epigenetic Modulation of Opioid Receptors by Drugs of Abuse.

Authors:  Ke Zhang Reid; Brendan Matthew Lemezis; Tien-Chi Hou; Rong Chen
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

Review 6.  From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks.

Authors:  Nikolai Jaschke; Sophie Pählig; Ying-Xian Pan; Lorenz C Hofbauer; Andy Göbel; Tilman D Rachner
Journal:  Trends Endocrinol Metab       Date:  2021-03-03       Impact factor: 12.015

7.  HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants.

Authors:  Sebastian Fritzwanker; Lionel Moulédous; Catherine Mollereau; Carine Froment; Odile Burlet-Schiltz; Felix Effah; Alexis Bailey; Mariana Spetea; Rainer K Reinscheid; Stefan Schulz; Andrea Kliewer
Journal:  Commun Biol       Date:  2021-09-14

Review 8.  Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models.

Authors:  Wenjian Kang; Shan Liu; Jin Xu; Anna Abrimian; Ayma F Malik; Raymond Chien; Adejuyigbe Adaralegbe; Akwasi Amponsah; Luca Cartegni; John Pintar; Ying-Xian Pan
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.